Roeland E Wasmann (Roeland Wasmann)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 24

Top Topics

Antiretroviral Therapy

Pulmonary Tuberculosis

Top Venues

British journal of clinical pharmacology

American journal of respiratory and critical care medicine

CPT: pharmacometrics & systems pharmacology

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Manna Semere Gebreyesus, Alexandra Dresner, Lubbe Wiesner, Ettienne Coetzee, Tess Verschuuren, Roeland E Wasmann, Paolo Denti
Dose optimization of cefazolin in South African children undergoing cardiac surgery with cardiopulmonary bypass. CPT: pharmacometrics & systems pharmacology (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Lufina Tsirizani Galileya, Shaghayegh Mohsenian Naghani, Hylke Waalewijn, Alexander J Szubert, Veronica Mulenga, Chishala Chabala, Mutsa Bwakura-Dangarembizi, Moses Chitsamatanga, Diana A Rutebarika, Victor Musiime, Mariam Kasozi, Abbas Lugemwa, Lara N Monkiewicz, Helen M McIlleron, David M Burger, Diana M Gibb, Paolo Denti, Roeland E Wasmann, Angela Colbers
Pharmacokinetics of once-daily darunavir/ritonavir in second-line treatment in African children with HIV. The Journal of antimicrobial chemotherapy (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology 90 (5) (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Hylke Waalewijn, Roeland E Wasmann, Alasdair Bamford, Diana Gibb, Helen M McIlleron, Angela Colbers, David Burger, Paolo Denti, null null
Population pharmacokinetics of Dolutegravir in African Children: results from the CHAPAS-4 trial. Journal of the Pediatric Infectious Diseases Society (2024)
Rephaim Mpofu, Aida Nakayiwa Kawuma, Roeland E Wasmann, Godspower Akpomiemie, Nomathemba C Chandiwana, Simiso Mandisa Sokhela, Michelle A Moorhouse, Willem Daniel Francois Venter, Paolo Denti, Lubbe Wiesner, Frank A Post, David W Haas, Gary Maartens, Phumla Z Sinxadi
Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. British journal of clinical pharmacology (2024)
Renu Verma, Kesia Esther da Silva, Neesha Rockwood, Roeland E Wasmann, Nombuso Yende, Taeksun Song, Eugene Kim, Paolo Denti, Robert John Wilkinson, Jason R Andrews
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing. American journal of respiratory and critical care medicine 209 (12) (2024)
Lufina Tsirizani Galileya, Roeland E Wasmann, Chishala Chabala, Helena Rabie, Janice Lee, Irene N Mukui, Anneke Hesseling, Heather J Zar, Rob Aarnoutse, Anna Turkova, Diana M Gibb, Mark Fredric Cotton, Helen M McIlleron, Paolo Denti
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. PLoS medicine 20 (11) (2023)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Phumla Z Sinxadi, Simiso Mandisa Sokhela, Nomathemba C Chandiwana, Willem Daniel Francois Venter, Lubbe Wiesner, Gary Maartens, Paolo Denti
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population. CPT: pharmacometrics & systems pharmacology (2023)
Koen P van Rhee, Cornelis Smit, Roeland E Wasmann, Paul D van der Linden, Marinus J Wiezer, Eric P A Van Dongen, Elke H J Krekels, Roger J M Brüggemann, Catherijne A J Knibbe
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. Clinical pharmacokinetics 61 (8) (2022)
Rulan Griesel, Aida N Kawuma, Roeland E Wasmann, Simiso Sokhela, Godspower Akpomiemie, W D Francois Venter, Lubbe Wiesner, Paolo Denti, Phumla Sinxadi, Gary Maartens
Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy. British journal of clinical pharmacology 88 (3) (2022)
Manna Semere Gebreyesus, Eric H Decloedt, Catherine Anne Cluver, Nicole Geertruida Maria Hunfeld, Hólmfríður Helgadóttir, Einar Stefan Björnsson, Roeland E Wasmann, Paolo Denti
Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia. British journal of clinical pharmacology 88 (10) (2022)
Lu Chen, Koen P van Rhee, Roeland E Wasmann, Elke H J Krekels, Marinus J Wiezer, Eric P A van Dongen, Paul E Verweij, Paul D van der Linden, Roger J M Brüggemann, Catherijne A J Knibbe
Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults. The Journal of antimicrobial chemotherapy 77 (8) (2022)
Aida Nakayiwa Kawuma, Roeland E Wasmann, Kelly E Dooley, Gary Maartens, Paolo Denti
Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model. British journal of clinical pharmacology (2022)
Paolo Denti, Roeland E Wasmann, Annelies van Rie, Jana Winckler, Adrie Bekker, Helena Rabie, Anneke C Hesseling, Louvina E van der Laan, Carmen Gonzalez-Martinez, Heather J Zar, Gerry Davies, Lubbe Wiesner, Elin M Svensson, Helen M McIlleron
Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: a prospective population pharmacokinetic study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Roeland E Wasmann, Elin M Svenson, Ann Sarah Walker, Michelle N Clements, Paolo Denti
Constructing a representative in-silico population for paediatric simulations: Application to HIV-positive African children. British journal of clinical pharmacology 87 (7) (2021)
Roeland E Wasmann, Elin M Svensson, Stein J Schalkwijk, Roger J Brüggemann, Rob Ter Heine
Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies. European journal of clinical pharmacology 77 (5) (2020)
Eline W Muilwijk, Dylan W de Lange, Jeroen A Schouten, Roeland E Wasmann, Rob Ter Heine, David M Burger, Angela Colbers, Pieter J Haas, Paul E Verweij, Peter Pickkers, Roger J M Brüggemann
Suboptimal Dosing of Fluconazole in Critically Ill Patients: Time To Rethink Dosing. Antimicrobial agents and chemotherapy 64 (10) (2020)
Johannes J M Rood, Amer Jamalpoor, Stéphanie van Hoppe, Matthijs J van Haren, Roeland E Wasmann, Manoe J Janssen, Alfred H Schinkel, Rosalinde Masereeuw, Jos H Beijnen, Rolf W Sparidans
Extrahepatic metabolism of ibrutinib. Investigational new drugs 39 (1) (2020)
Cornelis Smit, Roeland E Wasmann, Sebastiaan Camiel Goulooze, Marinus J Wiezer, Eric P A van Dongen, Johan W Mouton, Roger J M Brüggemann, Catherijne A J Knibbe
Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals. British journal of clinical pharmacology 86 (2) (2020)
Roeland E Wasmann, Rob Ter Heine, Eric P van Dongen, David M Burger, Vincent J Lempers, Catherijne A Knibbe, Roger J M Brüggemann
Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults. Antimicrobial agents and chemotherapy 62 (7) (2018)